胆管癌血清肿瘤标志物检测的新进展
|
摘要
胆管癌为罕见肿瘤,因为该病症隐匿,在早期的时候难以进行诊断。大多数的患者为在肿瘤转移或浸润的时候才被发现,因此患该病的患者预后比较差,生存率也比较低。血清肿瘤标志物检测为无创检测方式,有助于在早期发现胆管癌,有利于改善患者的预后。本文主要对胆管癌应用血清肿瘤标志物检测具有的价值,希望能够为临床诊断提供科学建议。
Cholangiocarcinoma is a rare neoplasm, because it is hidden and difficult to diagnose in the early stage. Most patients are only found when the tumor metastases or invades, so the prognosis of patients with this disease is poor and the survival rate is relatively low. Detection of serum tumor markers is a non-invasive method, which is helpful to early detection of cholangiocarcinoma and improve the prognosis of patients. This article is mainly about the value of serum tumor markers detection in cholangiocarcinoma,hoping to provide scientific suggestions for clinical diagnosis.
Cholangiocarcinoma is a rare neoplasm, because it is hidden and difficult to diagnose in the early stage. Most patients are only found when the tumor metastases or invades, so the prognosis of patients with this disease is poor and the survival rate is relatively low. Detection of serum tumor markers is a non-invasive method, which is helpful to early detection of cholangiocarcinoma and improve the prognosis of patients. This article is mainly about the value of serum tumor markers detection in cholangiocarcinoma,hoping to provide scientific suggestions for clinical diagnosis.
引文
[1]陶晓军,陈桂明,陈林琴,等.肿瘤标志物CEA、CA199和AFP在直结肠恶性肿瘤诊断中的应用及对近期有效率的影响[J].河北医药,2018,40(24):3753-3755+3759.
[2]徐超,黄秋兰,杜金龙,等.CEA、CA199、CA724、NSE和CYFR211联合检测对老年胃癌的诊断价值[J].中国老年学杂志,2018,38(23):5701-5703.
[3]万军.血清肿瘤标志物CA153,CA125,CEA和HER-2联合检测在乳腺癌诊断中的价值[J].现代检验医学杂志,2018,33(06):119-121.
[4]庞书杰,宿鑫成,杨宁,等.术前血清CA19-9水平对乙肝相关性肝内胆管细胞癌根治术后预后影响分析[J].肝胆胰外科杂志,2016,28(03):188-192.
[5]未万东.肿瘤标志物Cyfra21-1、NSE、CEA、CA125与肺癌骨转移的相关性[J].临床输血与检验,2018,20(05):514-517.
[6]龚时夏,尤建良.清气化痰汤联合化疗对中晚期非小细胞肺癌痰热阻肺证患者CEA、CA125及Cyfra21-1水平的影响[J].世界中医药,2017,12(12):2935-2938.
[7]宁怡蒙,宋敏,孟宇,等.血清CEA、CYFRA21-1、NSE联合检测在肺大细胞神经内分泌癌诊断中的应用价值[J].河南医学研究,2017,26(24):4431-4433.
[8]王丹.肿瘤标志物CA153、CA125检验在肺癌诊断中的应用价值[J].临床医学,2017,37(11):1-3.
[9]张英平,潘春荣,卢锦沛.血清肿瘤标志物AFP、CEA联合检测对原发性肝癌的诊断及预后评估价值分析[J].中国医药科学,2017,7(21):140-142.
[10]廖贵莉,张月霞,许秀军.血清淀粉样蛋白A联合肿瘤标志物检测在肺癌中的应用[J].国际检验医学杂志,2016,37(24):3500-3501.
[11]顾岩,乔晓娟,高俊珍,等.肿瘤标志物在良恶性胸腔积液的诊断价值[J].内蒙古医学杂志,2016,48(12):1419-1424.
[2]徐超,黄秋兰,杜金龙,等.CEA、CA199、CA724、NSE和CYFR211联合检测对老年胃癌的诊断价值[J].中国老年学杂志,2018,38(23):5701-5703.
[3]万军.血清肿瘤标志物CA153,CA125,CEA和HER-2联合检测在乳腺癌诊断中的价值[J].现代检验医学杂志,2018,33(06):119-121.
[4]庞书杰,宿鑫成,杨宁,等.术前血清CA19-9水平对乙肝相关性肝内胆管细胞癌根治术后预后影响分析[J].肝胆胰外科杂志,2016,28(03):188-192.
[5]未万东.肿瘤标志物Cyfra21-1、NSE、CEA、CA125与肺癌骨转移的相关性[J].临床输血与检验,2018,20(05):514-517.
[6]龚时夏,尤建良.清气化痰汤联合化疗对中晚期非小细胞肺癌痰热阻肺证患者CEA、CA125及Cyfra21-1水平的影响[J].世界中医药,2017,12(12):2935-2938.
[7]宁怡蒙,宋敏,孟宇,等.血清CEA、CYFRA21-1、NSE联合检测在肺大细胞神经内分泌癌诊断中的应用价值[J].河南医学研究,2017,26(24):4431-4433.
[8]王丹.肿瘤标志物CA153、CA125检验在肺癌诊断中的应用价值[J].临床医学,2017,37(11):1-3.
[9]张英平,潘春荣,卢锦沛.血清肿瘤标志物AFP、CEA联合检测对原发性肝癌的诊断及预后评估价值分析[J].中国医药科学,2017,7(21):140-142.
[10]廖贵莉,张月霞,许秀军.血清淀粉样蛋白A联合肿瘤标志物检测在肺癌中的应用[J].国际检验医学杂志,2016,37(24):3500-3501.
[11]顾岩,乔晓娟,高俊珍,等.肿瘤标志物在良恶性胸腔积液的诊断价值[J].内蒙古医学杂志,2016,48(12):1419-1424.